Recent market research by Future Market Insights (FMI) highlights robust growth in the global molecular quality controls market. Valued at USD 204 million in 2023, the market is expected to advance at a compound annual growth rate (CAGR) of 7.2%, reaching an estimated USD 408 million by 2033. This expansion underscores the increasing demand for high-quality molecular diagnostic solutions across healthcare and research sectors.
Molecular quality controls are integral to ensuring the reliability and accuracy of molecular diagnostic tests, which are widely used for detecting genetic disorders, infectious diseases, and cancer biomarkers. With the growing adoption of advanced diagnostic technologies and the rising prevalence of chronic and infectious diseases, the demand for molecular quality controls is escalating.
Key market drivers include advancements in molecular diagnostic technologies, regulatory requirements for laboratory accreditation, and increased awareness among laboratories about the importance of quality controls. Leading players are focusing on developing innovative, customizable, and user-friendly molecular quality control products to address the diverse needs of clinical laboratories and research facilities.
Key Takeaways:
- The molecular quality controls market is projected to grow from USD 204 million in 2023 to USD 408 million by 2033, at a CAGR of 7.2%.
- Rising adoption of molecular diagnostics and the increasing prevalence of chronic and infectious diseases are driving market growth.
- Advancements in quality control products and regulatory demands for laboratory accuracy are boosting demand.
- Market players are emphasizing innovation to deliver customized solutions for clinical and research applications.
Key factors that might propel the market growth are:
- The surge in the clinical laboratories owing to rising diseases
- Increasing consumer awareness regarding the importance of accreditation from government bodies
- The rising dependence on third-party quality controls
Worldwide, there has been an exponential surge in people suffering from various diseases owing to a lot of factors. To meet the burgeoning demand for conducting laboratory tests for these patients, both public and private sector players are investing in molecular quality controls. These players develop processes that fall in line with the standards set by regulatory bodies, like International Organization for Standardization.
Request a Sample Report Now to get Premium Insights: https://www.fmisamplereport.com/sample/rep-gb-14301
Manufacturers Offer a One-of-a-kind Mixed Reality Experience for Blood Donors
The key players operating in the market are introducing an innovative ‘mixed reality experience’ for use, which is specially designed for blood donors. The innovation is done to improve the experience and attract young blood donors to motivate them for donating blood. In January 2023, Abbott and Blood Centers of America launched first of its kind mixed reality experience for use during blood donation.
Key developments in the market:
- In January 2023, Abbott received FDA approval for NAVIATOR, a next-generation TAVI system designed to treat aortic stenosis.
- In September 2022, LGC’s new state-of-the-art site in Oxford delivered critical diagnostics solutions and research.
Molecular Quality Controls Market Segmentation
By Analyte:
- Single-analyte Controls
- Multi-analyte Controls
By Product Type:
- Independent controls
- Instrument-specific controls
By Application:
- Infectious Diseases Diagnostics
- Oncology Testing and Genetic testing
By End User:
- Diagnostic laboratories
- Hospitals
- IVD manufacturers & CROs
- Academic & Research Institutes
By Region:
- North America
- Latin America
- Asia Pacific
- The Middle East and Africa
- Europe
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube